Hepatitis viruses: Their role in human cancer

Proceedings of the Association of American Physicians

Volumn 111, Issue 6, 1999, Pages 588-593

  Bradley, D W ^a  

^a NONE   (United States)

Author keywords

Hepatitis B Virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

ALPHA INTERFERON; HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENICITY; CELL TRANSFORMATION; GENE MUTATION; HEPADNAVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS VIRUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALIGNANT TRANSFORMATION; NONHUMAN; PROMOTER REGION; REVIEW; VIRUS INFECTION;

EID: 0032701493     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.t01-1-99240.x     Document Type: Review

References (29)

1. 1 Bosch F.X. Global epidemiology of hepatocellular carcinoma. In: Liver Cancer. Okuda K. and Tabor E. (eds). New York: Churchill Livingstone, 1997. Pp. 13–28.
2. 2 Choo Q.‐L., Kuo G., Weiner A.W., et al. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome. Science 244: 359 362, 1989.
3. 3 Kuo G., Choo Q.‐L., Alter H.J., et al. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis. Science 244: 362 364, 1989.
4. 4 Pineau P. and Tiollais P. Animal hepadnaviruses as a model of carcinogenesis. In: Liver Cancer. Okuda K. and Tabor E. (eds). New York: Churchill Livingstone, 1997. Pp. 189–197.
5. 5 Rogler C.E. & Summers J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J. Virol. 50: 832 837, 1984.
6. 6 Yamazoe M., Nakai S., Ogasawara N., Yoshikawa H. Integration of woodchuck hepatitis virus (WHV) DNA at two chromosomal sites (Vk and gag–like) in a hepatocellular carcinoma. Gene 100: 139 146, 1991.
7. 7 Rakotomahanina C.K., Hilger C., Fink T., et al. Biological activities of a putative truncated hepatitis B virus X gene product fused to a polylysine stretch. Oncogene 9: 2613 2621, 1994.
8. 8 Wei Y., Etiemble J., Fourel G., et al. Hepadnavirus integration generates virus‐cell cotranscripts carrying 3′ truncated X genes in human and woodchuck liver tumors. J Med. Virol. 45: 82 90, 1995.
9. 9 Kim C.‐M., Koike K., Saito I., et al. The HBx gene of hepatitis B virus induces liver cancer. Nature 351: 317 320, 1991.
10. 10 Ueda H., Ohkoshi S., Kim C.‐M., and Jay G. A transgenic mouse model of HBV‐related hepatocellular carcinoma. In: Liver Cancer. Okuda K. and Tabor E. (eds). New York: Churchill Livingstone, 1997. Pp. 201–211.
11. 11 Sato S., Suzuki K., Akahane Y., et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann. Intern. Med. 122: 241 248, 1995.
12. 12 Laskus T., Radlowski M., Nowicki M., et al. Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 244: 812 814, 1998.
13. 13 Park Y.M., Kim B.S., Tabor E. Precore codon 28 stop mutation in hepatitis B virus from patients with hepatocellular carcinoma. Korean J. Intern. Med. 12: 201 207, 1997.
14. 14 Raimondo G., Campo S., Smedile V., et al. Hepatitis B virus variant, with a deletion in the preS2 and two translational stop codons in the precore regions, in a patient with hepatocellular carcinoma. J. Hepatol. 13 (Suppl. 4): S74 S77, 1991.
15. 15 Kidd‐Ljunggren K., Oberg M., Kidd A.H. Hepatitis B virus X gene 1751–1764 mutations: Implications for HBeAg status and disease. J. Gen. Virol. 78: 1469 1478, 1997.
16. 16 Hsia C.C., Yuwen H., Tabor E. Hot‐spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet 348: 625 626, 1996.
17. 17 Hsia C.C., Nakashima Y., Tabor E. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 241: 726 729, 1997.
18. 18 Yuwen H., Hsia C.C., Nakashima Y., et al. Binding of wild‐type p53 topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 234: 194 197, 1997.
19. 19 Caselman W.H. & Alt M. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J. Hepatol. 24 (Suppl.): 61 66, 1996.
20. 20 Castells L., Vargas V., Gonzalez A., et al. Long interval between HCV infection and development of hepatocellular carcinoma. Liver 15: 159 163, 1995.
21. 21 Di Bisceglie A.M. Hepatitis C and hepatocellular carcinoma. Hepatology 26 (Suppl. 1): 34S 38S, 1997.
22. 22 Saito K., Sullivan D., Haruna Y., et al. Detection of hepatitis C virus RNA sequences in hepatocellular carcinoma and its precursors by microdissection polymerase chain reaction. Arch. Pathol. Lab. Med. 121: 400 403, 1997.
23. 23 El‐Rafaie A., Savage K., Bhattacharya S., et al. HCV‐associated hepatocellular carcinoma with cirrhosis. J. Hepatol. 24: 277 285, 1996.
24. 24 Tanaka K., Sata M., Uchimura Y., et al. Long‐term evaluation of interferon therapy in hepatitis C virus‐associated cirrhosis: Does IFN prevent development of hepatocellular carcinoma? Oncol. Res. 5: 205 208, 1998.
25. 25 Naoumov N.V., Chokshi S., Metivier E., et al. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J. Hepatol. 27: 331 336, 1997.
26. 26 Tanaka K., Ikematsu H., Hirohata T., Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: Possible role of type 1b (II) infection. J. Natl. Cancer Inst. 88: 742 746, 1996.
27. 27 Zein N.N., Poterucha J.J., Gross J.B., et al. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am. J. Gastroenterol. 91: 2560 ‐ 2562, 1996.
28. 28 Shimizu I., Yao D.F., Horie C., et al. Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma. J. Gastroenterol. 32: 47 55, 1997.
29. 29 Inoue Y., Miyazaki M., Ohashi R., et al. Ubiquitous presence of cellular proteins that specifically bind to the 3′ terminal region of the hepatitis C virus. Biochem. Biophys. Res. Commun. 245: 198 203, 1998.